The effects of intracerebroventricular AM-251, a CB1-receptor antagonist, and ACEA, a CB1-receptor agonist, on penicillin-induced epileptiform activity in rats

被引:50
|
作者
Kozan, Ramazan [1 ]
Ayyildiz, Mustafa [1 ]
Agar, Erdal [1 ]
机构
[1] Ondokuz Mayis Univ, Fac Med, Dept Physiol, TR-55139 Samsun, Turkey
关键词
AM251; ACEA; Cannabinoids; Epileptiform activity; Penicillin; PENTYLENETETRAZOLE-INDUCED SEIZURE; CB1 RECEPTOR ANTAGONIST; NEURONAL CULTURE MODEL; CANNABINOID RECEPTOR; ACQUIRED EPILEPSY; MICE; ENDOCANNABINOIDS; CEREBELLUM; GABA; DELTA(9)-TETRAHYDROCANNABIVARIN;
D O I
10.1111/j.1528-1167.2009.02098.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P>Purpose: Several results support the conclusion that the cannabinoid system has a role in generation and cessation of epileptic seizures. The aim of this study was to evaluate the effects of intracerebroventricular AM-251 [N-(piperidin-1-yl)-5-(4-iodophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide], a CB1-receptor antagonist, and ACEA (arachidonyl-2-chloroethylamide), a CB1-receptor agonist, on penicillin-induced epileptiform activity in rats. Methods: In the first set of experiments, 30 min after penicillin injection, AM-251, at doses of 0.125, 0.25, 0.5, and 1 mu g, was administered intracerebroventricularly (i.c.v.). In the second set of experiments, 30 min after penicillin injection, ACEA, at doses of 2.5, 5, 7.5, and 15 mu g (i.c.v.), was administered. In the third set of experiments, AM-251, at doses of 0.125 and 0.25 mu g (i.c.v.), was administered 10 min before ACEA (7.5 mu g, i.c.v.) injection. Results: ACEA, at a dose of 7.5 mu g, significantly decreased the frequency of penicillin-induced epileptiform activity without changing the amplitude. ACEA, at doses of 2.5, 5, and 15 mu g, had no impact on either frequency or amplitude of epileptiform activity. AM-251, at doses of 0.25 and 0.50 mu g, significantly increased the frequency of epileptiform activity. AM-251, at a dose of 0.25 mu g (i.c.v.), was the most effective in changing the frequency of penicillin-induced epileptiform activity, and it also caused status epilepticus-like activity. AM-251, at doses of 0.125 and 0.25 mu g, 10 min before ACEA (7.5 mu g), reversed the anticonvulsant action of ACEA. Discussion: The results of the present study provide electrophysiologic evidence for the role of CB1 receptors in regulating the frequency of epileptiform activity in the model of penicillin-induced epilepsy. To elucidate the precise mechanism of cannabinoid action in the brain during seizure, more advanced electrophysiologic and neurochemical studies are required.
引用
收藏
页码:1760 / 1767
页数:8
相关论文
共 50 条
  • [31] Voluntary exercise augments acute effects of CB1-receptor inverse agonist on body weight loss in obese and lean mice
    Zhou, D
    Shearman, LP
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2004, 77 (01) : 117 - 125
  • [32] The Effect of CB1 Receptor Agonist and Antagonist on the Epileptiform Activity in a Pentylenetetrazole Kindling Rat Model
    Al Kaleel, Ali Zaher Kamel
    Aygun, Hatice
    Kamil, Lubna Adil Kamil
    Kabak, Yonca
    Inal, Sinem Beyazkilinc
    Ayyildiz, Mustafa
    Him, Aydin
    Agar, Erdal
    [J]. ACTA PHYSIOLOGICA, 2019, 227 : 76 - 76
  • [33] Acute anorectic response to cannabinoid CB1 receptor antagonist/inverse agonist AM 251 in rats: indirect behavioural mediation
    Tallett, Amy J.
    Blundell, John E.
    Rodgers, John R.
    [J]. BEHAVIOURAL PHARMACOLOGY, 2007, 18 (07): : 591 - 600
  • [34] Cannabinoid CB1-receptor mediated regulation of gastrointestinal motility in mice in a model of intestinal inflammation
    Izzo, AA
    Fezza, F
    Capasso, R
    Bisogno, T
    Pinto, L
    Iuvone, T
    Esposito, G
    Mascolo, N
    Di Marzo, V
    Capasso, F
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2001, 134 (03) : 563 - 570
  • [35] Anticonvulsant effects of focal and intracerebroventricular adenosine on penicillin-induced epileptiform activity in rats
    Yildirim, Mehmet
    Marangoz, Cafer
    [J]. BRAIN RESEARCH, 2007, 1127 (01) : 193 - 200
  • [36] In-vivo pharmacological evaluation of the CB1-receptor allosteric modulator Org-27569
    Gamage, Thomas F.
    Ignatowska-Jankowska, Bogna M.
    Wiley, Jenny L.
    Abdelrahman, Mostafa
    Trembleau, Laurent
    Greig, Iain R.
    Thakur, Ganesh A.
    Tichkule, Ritesh
    Poklis, Justin
    Ross, Ruth A.
    Pertwee, Roger G.
    Lichtman, Aron H.
    [J]. BEHAVIOURAL PHARMACOLOGY, 2014, 25 (02): : 182 - 185
  • [37] Effects of CB2 receptor agonist palmitoylethanolamide and CB2 receptor antagonist AM 630 on leucocyte phagocytic activity in mice
    Vinklerová, J
    Sulcová, A
    [J]. BEHAVIOURAL PHARMACOLOGY, 2002, 13 (5-6): : 507 - 508
  • [38] The CB1 inverse agonist AM251, but not the CB1 antagonist AM4113, enhances retention of contextual fear conditioning in rats
    Sink, K. S.
    Segovia, K. N.
    Collins, L. E.
    Markus, E. J.
    Vemuri, V. K.
    Makriyannis, A.
    Salamone, J. D.
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2010, 95 (04) : 479 - 484
  • [39] Evaluation of the role of CB1-receptor in paraventricular nucleus on secretion of ghrelin hormone and feeding behaviour in rat
    Bahari, Zahra
    Moghaddam, Hadi Fathi
    Ahangarpur, Akram
    Dianat, Mahin
    Mard, Seyed Ali
    Eshaghi, Nasrin
    [J]. NEUROSCIENCE RESEARCH, 2011, 71 : E266 - E266
  • [40] Links between central CB1-receptor availability and peripheral endocannabinoids in patients with first episode psychosis
    Dickens, Alex M.
    Borgan, Faith
    Laurikainen, Heikki
    Lamichhane, Santosh
    Marques, Tiago
    Ronkko, Tuukka
    Veronese, Mattia
    Lindeman, Tuomas
    Hyotylainen, Tuulia
    Howes, Oliver
    Hietala, Jarmo
    Oresic, Matej
    [J]. NPJ SCHIZOPHRENIA, 2020, 6 (01):